Physician, patient, and caregiver education is important to improve diabetes care, said Jaime A. Davidson, MD, FACP, MACE, professor of medicine, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center.
Physician, patient, and caregiver education is important to improve diabetes care, said Jaime A. Davidson, MD, FACP, MACE, professor of medicine, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center.
Transcript
What is the number one unmet need in diabetes that you would like to solve first?
There are many. There are so many. The first thing is to think that it’s better to prevent and we have different types of prevention; one is primary prevention. That’s preventing diabetes. That requires educating the public, the family members of somebody with diabetes, educate their physicians in primary care, in endocrinology, in cardiology.
And then there’s secondary prevention. That means somebody already has diabetes, we don’t want that patient to have complications. So, we need to educate the patients to take better care of their glucose levels, to take the medications properly. We give them a drug to lower cholesterol, they need to know they need to take it on a regular basis. If they’re taking blood pressure medications, why should they take them? When they should take them? And it is polypharmacy. And whenever we have polypharmacy, the adherence to those drugs goes down. So, one thing that is a real unmet need, is to teach physicians, as well as patients, that adherence is very important.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More